CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409
Publication
, Conference
Jiang, H; Chen, HC; Bashir, M
Published in: HEPATOLOGY
2020
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
900A / 900A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Jiang, H., Chen, H. C., & Bashir, M. (2020). CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409. In HEPATOLOGY (Vol. 72, pp. 900A-900A).
Jiang, Hanyu, Hubert C. Chen, and Mustafa Bashir. “CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409.” In HEPATOLOGY, 72:900A-900A, 2020.
Jiang H, Chen HC, Bashir M. CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409. In: HEPATOLOGY. 2020. p. 900A-900A.
Jiang, Hanyu, et al. “CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409.” HEPATOLOGY, vol. 72, 2020, pp. 900A-900A.
Jiang H, Chen HC, Bashir M. CHANGE IN LIVER FAT CONTENT AT 4 WEEKS ACCURATELY PREDICTS CHANGE IN LIVER FAT CONTENT AT 12 WEEKS IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS TREATED WITH AN FXR AGONIST: ANALYSIS FROM A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH MET409. HEPATOLOGY. 2020. p. 900A-900A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
900A / 900A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics